UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

CVRx, INC.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

126638105

(CUSIP Number)

December 31, 2021

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CVRx, Inc. (the “Issuer”)

9201 West Broadway Avenue, Suite 650

Minneapolis, MN 55445

This joint statement on Schedule 13G is being filed by Vensana Capital I, L.P. (“Vensana I”), Vensana Capital I GP, LLC (“Vensana GP I” and together with Vensana I, the “Reporting Entities”) and Kirk Nielsen (“Nielsen”) and Peter Justin Klein (“Klein” and together with Nielsen, the “Managing Directors”). The Reporting Entities and the Managing Directors collectively are referred to as the “Reporting Persons”.

The address of the principal business office of each Reporting Person is 3601 W. 76^th Street, Suite 20, Edina, Minnesota 55435.

Vensana GP I is a limited liability company organized under the laws of the State of Delaware. Vensana I is a limited partnership organized under the laws of the State of Delaware. Each of the Managing Directors is a citizen of the United States of America.

Common Stock, $0.01 par value per share (“Common Stock”).

126638105

Not applicable.

See Row 9 of the cover page for each Reporting Person. Vensana I is the record owner of the 1,461,831 shares of Common Stock (the “Vensana Shares”). As the general partner of Vensana I, Vensana GP I may be deemed to beneficially own the Vensana Shares. As the managing directors of Vensana GP I, each of the Managing Directors also may be deemed to beneficially own the Vensana Shares.

See Row 11 of the cover page for each Reporting Person and the corresponding footnotes.*

        (c) Number of shares as to which the person has:

See Row 5 of the cover page for each Reporting Person and the corresponding footnotes.*

See Row 6 of the cover page for each Reporting Person and the corresponding footnotes.*

See Row 7 of the cover page for each Reporting Person and the corresponding footnotes.*

See Row 8 of the cover page for each Reporting Person and the corresponding footnotes.*

Not applicable.

Under certain circumstances set forth in the limited partnership agreement of Vensana I and the limited liability company agreement of Vensana GP I, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of securities of the Issuer owned by each such entity of which they are a partner or member, as the case may be.

Not applicable.

Not applicable.

Not applicable.

Not Applicable

Material to be Filed as Exhibits.

Exhibit 1 – Joint Filing Agreement.

Exhibit 2 – Power of Attorney

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 10, 2022

[*This Schedule 13G was executed pursuant to a Power of Attorney. Note that a copy of the applicable Power of Attorney is included as an exhibit to this Schedule 13G.]

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the timely filing of such statement on Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others of the undersigned, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate or incomplete. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated: February 10, 2022

[**This joint filing statement was executed pursuant to a Power of Attorney. Note that a copy of the applicable Power of Attorney is included as an exhibit to this Schedule 13G.]

Exhibit 2

POWER OF ATTORNEY

March 18, 2021

Each of the undersigned, including (i) Vensana Capital I GP, LLC, a Delaware limited liability company (the “Fund I GP”), in the normal course of its business and in its capacity as the general partner of Vensana Capital I, L.P., (ii) Vensana Capital Management, LLC, a Delaware limited liability company (the “Management Company”) and (iii) each of Kirk Nielsen and Peter Justin Klein (the “Managing Directors”) in their respective capacities as the managing directors of the General Partner and the Management Company, hereby constitutes and approves STEVEN SCHWEN (the “Attorney-in-Fact”) as the undersigned’s true and lawful attorney-in-fact to:

(1) Execute for and on behalf of the undersigned any and all documents, agreements, filings, reports, consents, waivers, certificates, forms, proxies, notices or communications, or amendments or modifications to any of the foregoing, requested by the undersigned in connection with the conduct of the undersigned’s business (collectively, the “Documents”);

(2) Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any and all such Documents;

(3) Execute for and on behalf of each of the undersigned (a “Reporting Person”) any and all reports, notices, communications and other documents (including, but not limited to, reports on Schedule 13D, Schedule 13F, Schedule 13G, Form 13H, Form 13-F, Form 3, Form 4 and Form 5) that such Reporting Person may be required to file with the United States Securities and Exchange Commission pursuant to the U.S. Securities Act of 1933, as amended, and the U.S. Securities Exchange Act of 1934, as amended (collectively, the “Reports”) with respect to each Reporting Person’s (a) status as an officer or director of, or (b) ownership of, or transactions in, securities of, any entity whose securities are beneficially owned (directly or indirectly) by the applicable Reporting Person;

(4) Do and perform any and all acts for and on behalf of each of the undersigned which may be necessary or desirable to complete and execute any such Reports and timely file such forms and schedules with the United States Securities and Exchange Commission and any other stock exchange or similar authority; and

(5) Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of the Attorney-in-Fact, may be of benefit to, in the best interest of, or legally required by, each of the undersigned, it being understood that the documents executed by the Attorney-in-Fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as the Attorney-in-Fact may approve in his discretion.

In exercising the powers granted herein, the Attorney-in-Fact may execute any and all Documents and Reports (i) on behalf of the Fund I GP or Management Company as “Chief Financial Officer” (or “CFO”) or (ii) on behalf of any of the undersigned as an “Authorized Person”, “Authorized Signatory” or “Attorney-in-Fact.”

Each of the undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that the Attorney-in-Fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.

Each Reporting Person acknowledges that the Attorney-in-Fact, in serving in such capacity at the request of each such Reporting Person, is in no way hereby assuming, nor is any other Reporting Person hereby assuming, any of each such Reporting Person’s responsibilities under the laws of the United States or any state, including without limitation, compliance with Section 16 or Section 13 of the U.S. Securities Exchange Act of 1934, as amended.

This Power of Attorney granted to the Attorney-in-Fact replaces in full that certain Power of Attorney executed by the Fund I GP and the Management Company with respect to the Attorney-in-Fact as of February 11, 2021 and shall remain in full force and effect with respect to each of the undersigned until (x) the Attorney-in-Fact is no longer employed by or otherwise serving as Chief Financial Officer of the Management Company, or (y) a Reporting Person earlier revokes this Power of Attorney with respect to such Reporting Person by delivering written notice of such revocation to the Attorney-in-Fact.

[Signature pages follow.]

IN WITNESS WHEREOF, each of the undersigned has caused this Power of Attorney to be executed effective as of the date first set forth above.